FDA Inspection 1242125 — H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.
The FDA completed an inspection of H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. on May 23, 2024 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 23, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tampa, FL (United States)